title: Recombinant factor VIIa treatment for life-threatening haemoptysis.
abstract: Diffuse alveolar haemorrhage is a severe clinical disorder that may be life-threatening. The early diagnosis of diffuse alveolar haemorrhage and prompt intervention is crucial. Recombinant factor VIIa has been used extensively for the treatment of haemophilia A and B patients. More recently, recombinant factor VIIa has been used successfully for the treatment of bleeding in patients without pre-existing coagulopathy. We describe the successful use of recombinant factor VIIa in a patient with diffuse alveolar haemorrhage secondary to pulmonary-renal syndrome.
authors.affiliation: Department of Chest Disease, Osmangazi University, Medical Faculty, 26480 Meselik, Eskisehir, Turkey. heylul2002@yahoo.com
authors.forename: Huseyin
authors.initials: H
authors.lastname: Yildirim
authors.forename: Irfan
authors.initials: I
authors.lastname: Ucgun
authors.forename: Ahmet Ugur
authors.initials: AU
authors.lastname: Yalcin
authors.forename: Zafer
authors.initials: Z
authors.lastname: Gulbaş
authors.forename: Garip
authors.initials: G
authors.lastname: Sahin
authors.forename: Mustafa Fuat
authors.initials: MF
authors.lastname: Acikalin
authors.forename: Muzaffer
authors.initials: M
authors.lastname: Metintas
authors.forename: Guntulu
authors.initials: G
authors.lastname: Ak
mesh_terms: D000328:Adult; D003029:Coagulants / Q000627:therapeutic use*; D015942:Factor VIIa / Q000627:therapeutic use*; D006469:Hemoptysis / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008297:Male; D011650:Pulmonary Alveoli; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D003029:Coagulants; D011994:Recombinant Proteins; D015942:Factor VIIa